Indexed in
License and use
Grant support
The web platform PREDIRCAM2 was designed in a project funded by Instituto Carlos Tercero de Madrid (FIS PI12/00931) at the Endocrinology and Nutrition Department of Santa Creu I Sant Pau Hospital in Barcelona, and Centro de Tecnologia Biomedica, ETSI de Telecommunicacion at Universidad Politecnica de Madrid, Spain. V.A.-A. and A.L. have received scholarships from the Catalan administration (Departament d'Economia I Coneixement de la Generalitat de Catalunya, Fondo Social Europeo, AGAUR-FI-DGR). V.A.-A. received an award from Sociedad Espanola de Endocrinologia y Nutricion in alliance with MSD and the project received media resource collaboration from Roche Diabetes Care.
Analysis of institutional authors
Tapia, JoseAuthorManuel Iniesta, JoseAuthorElena Hernando, M.AuthorWeb Support for Weight-Loss Interventions: PREDIRCAM2 Clinical Trial Baseline Characteristics and Preliminary Results
Publicated to:Diabetes Technology & Therapeutics. 20 (5): 380-385 - 2018-05-01 20(5), DOI: 10.1089/dia.2017.0456
Authors: Alcantara-Aragon, Valeria; Rodrigo-Cano, Susana; Lupianez-Barbero, Ascension; Jose Martinez, Maria; Martinez, Carmen; Tapia, Jose; Manuel Iniesta, Jose; Tenes, Susana; Urgell, Eulalia; Navarro, Gemma; Elena Hernando, M; Francisco Merino-Torres, Juan; de Leiva, Alberto; Gonzalez, Cintia
Affiliations
Abstract
An ongoing clinical trial is testing the efficacy of web telematic support in a structured program for obesity treatment and diabetes prevention. Participants were recruited from two tertiary-care hospitals and randomized to receive either a telematic intervention (TI) supported by PREDIRCAM2 web platform or a non-telematic intervention (NTI). All receive 1-year follow-up. Both interventions consist of tailored dietary and exercise prescriptions, based on a Mediterranean dietary pattern and general WHO exercise recommendations for adults. At 6 months, both groups have received 7 contacts, 3 exclusively telematic for the TI group. This is a preliminary result intention-to-treat analysis. One hundred eighty-three participants were recruited, with a mean body mass index of 34.75 +/- 2.75kg/m(2). General dropout rate at 6 months was 26.8%. Weight changes were statistically significant at months 3 and 6 compared to baseline, -2.915 +/- 0.24kg, -3.29 +/- 0.36kg, respectively (P<0.001), but not statistically significant between the 3- and 6-month time points -0.37 +/- 0.21kg (P=0.24). Mean group differences showed that the TI group lost 1.61 +/- 1.88kg more than the NTI group (P=0.39). Waist, waist/hip ratio, resting heart rate, blood pressure, HbA1c, and low-density lipoprotein cholesterol also showed statistically significant changes at 6 months, with no significant differences between groups. Weight loss in the TI group shows similar results as the usual care NTI group for weight loss and control of obesity comorbidities. At completion of the clinical trial, these results will be reevaluated to assess the potential role of web support in weight-loss maintenance and its cost-effectiveness.
Keywords
Quality index
Bibliometric impact. Analysis of the contribution and dissemination channel
The work has been published in the journal Diabetes Technology & Therapeutics due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2018, it was in position 29/144, thus managing to position itself as a Q1 (Primer Cuartil), in the category Endocrinology & Metabolism.
From a relative perspective, and based on the normalized impact indicator calculated from the Field Citation Ratio (FCR) of the Dimensions source, it yields a value of: 1.84, which indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: Dimensions Apr 2025)
Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-04-30, the following number of citations:
- WoS: 5
- Scopus: 5
- Europe PMC: 1
- Google Scholar: 6
- OpenCitations: 4
